Skip to main content
NCBI home page
Journal of Athletic Training logoLink to Journal of Athletic Training
. 2008 Sep-Oct;43(5):534–536. doi: 10.4085/1062-6050-43.5.534

HORMONAL FACTORS

PMCID: PMC2547876  PMID: 18833319

What We Know

  1. A consensus is emerging from the literature that the likelihood of suffering an ACL injury is not evenly distributed across the menstrual cycle; instead, the risk of suffering an ACL disruption is greater during the preovulatory phase of the menstrual cycle than in the postovulatory phase.1–5 During the preovulatory phase, hormone levels are changing dramatically, falling to their nadirs with the onset of menses and once again rising rapidly near ovulation.

  2. Evidence exists for sex hormone receptors (estrogen, testosterone, and relaxin) on the human ACL.6–10

  3. Evidence exists for sex hormone receptors (estrogen, testosterone) on skeletal muscle.11–13

  4. Large individual variations in female hormone profiles should be appreciated in study designs.14

  5. Consistent with individual variability in hormone profiles, the magnitude of change in laxity (ie, anterior knee laxity, genu recurvatum) that females experience across the menstrual cycle varies substantially15 (abstract 19).

  6. Because of the individual variability in hormone profiles across the menstrual cycle, a single measurement within a single phase (even with hormonal confirmation) is not adequate to accurately characterize the same hormone profile or time point in a particular phase of the menstrual cycle for all females.

  7. The mechanical and molecular properties of the ACL are likely influenced not only by estrogen but by the interaction of several sex hormones, secondary messengers, remodeling proteins, and mechanical stresses.7,10,14,16–18

  8. A time-dependent effect exists for sex hormones and other remodeling agents to influence a change in ACL tissue characteristics.10,14

  9. Some evidence in animal models suggests interactions among mechanical stress, hormones, and altered ACL structure and metabolism.19–21

What We Don't Know

  1. What is the underlying mechanism for the increased likelihood of ACL injury in the preovulatory phase?

  2. How do ACL injury rates vary in females who are eumenorrheic or oligomenorrheic or using oral contraceptives?

  3. What are the effects of sex hormones on ACL structure, metabolism, and mechanical properties? The influence of hormones on ACL biology has been examined in a variety of animal models21–30 and relatively few human studies,18,31 but a consensus is lacking due to variations in study designs and the varieties of species examined.

  4. What is the role of hormones on skeletal muscle structure and function in controlling dynamic motion? What, if any, changes occur in neuromuscular and biomechanical risk factors across the menstrual cycle? Although previous authors have suggested that cyclical changes in neuromuscular and biomechanical control may be negligible,32–34 these results may be incomplete due to the individual variations in hormone profiles (see What We Know, items 3–5).

  5. Does the rate of increase or time duration of amplitude peaks in hormone fluctuations play a role in soft tissue changes?

  6. For those females who experience changes in knee laxity across the menstrual cycle, what are the clinical implications of these changes on weight-bearing knee joint stability and neuromechanics?

  7. What are the interactions among mechanical stress on the ACL, hormone profiles, and altered ACL structure and metabolism in physically active females?

Where We Go From Here

  1. We must continue to consider the interactive effect of all relevant hormones on soft tissue structures and ACL injury risk.

  2. The mechanisms by which sex hormones may explain sex-specific differences in ACL structure, metabolism, and mechanical properties that have been observed (also see Anatomical and Structural Factors) should be defined.

  3. More studies using research designs relevant to the healthy, physically active female are needed to examine hormonal effects on ACL structural, metabolic, and mechanical properties.

  4. When examining hormonal influences on knee joint function and ACL injury risk, females using oral contraceptives and those with irregular menstrual cycles (amenorrhea and oligomenorrhea) should also be investigated. The type of contraceptive should be documented and both the endogenous and exogenous levels of sex hormones evaluated.

  5. Future studies of hormone risk factors should focus more on individual results, rather than mean values, as much variability exists in individual menstrual cycle characteristics.

  6. Improved methods of measuring individual hormone profiles to better assess the complex roles of hormones in soft tissue changes should be developed. We need to verify phases of the cycle with actual hormone measures and consider all relevant hormones, including estrogen, progesterone, and possibly others. To confirm that the desired time in the cycle or a particular phase is truly captured in future study designs, hormone samples should be taken over multiple days rather than measured at a single time point.

  7. When making female-to-male comparisons, factors should be assessed during the early follicular phase, when hormone levels are at their nadirs (preferably 3–7 days postmenses) to decrease the potential for cyclic hormonal fluctuations to confound the anatomical, neuromuscular, and biomechanical outcomes of interest.

  8. The interaction among hormones, mechanical loading, and ACL mechanical properties in the physically active female should be examined.

References

  • 1.Arendt E.A, Bershadsky B, Agel J. Periodicity of noncontact anterior cruciate ligament injuries during the menstrual cycle. J Gend Spec Med. 2002;5((2)):19–26. [PubMed] [Google Scholar]
  • 2.Beynnon B.D, Johnson R.J, Braun S, et al. The relationship between menstrual cycle phase and anterior cruciate ligament injury: a case-control study of recreational alpine skiers. Am J Sports Med. 2006;34((5)):757–764. doi: 10.1177/0363546505282624. [DOI] [PubMed] [Google Scholar]
  • 3.Myklebust G, Engebretsen L, Braekken I.H, Skjolberg A, Olsen O.E, Bahr R. Prevention of anterior cruciate ligament injuries in female team handball players: a prospective intervention study over three seasons. Clin J Sport Med. 2003;13((2)):71–78. doi: 10.1097/00042752-200303000-00002. [DOI] [PubMed] [Google Scholar]
  • 4.Slauterbeck J.R, Fuzie S.F, Smith M.P, et al. The menstrual cycle, sex hormones, and anterior cruciate ligament injury. J Athl Train. 2002;37((3)):275–280. [PMC free article] [PubMed] [Google Scholar]
  • 5.Wojtys E.M, Huston L, Boynton M.D, Spindler K.P, Lindenfeld T.N. The effect of menstrual cycle on anterior cruciate ligament injuries in women as determined by hormone levels. Am J Sports Med. 2002;30((2)):182–188. doi: 10.1177/03635465020300020601. [DOI] [PubMed] [Google Scholar]
  • 6.Dragoo J.L, Lee R.S, Benhaim P, Finerman G.A, Hame S.L. Relaxin receptors in the human female anterior cruciate ligament. Am J Sports Med. 2003;31((4)):577–584. doi: 10.1177/03635465030310041701. [DOI] [PubMed] [Google Scholar]
  • 7.Faryniarz D.A, Bhargava M, Lajam C, Attia E.T, Hannafin J.A. Quantitation of estrogen receptors and relaxin binding in human anterior cruciate ligament fibroblasts. In Vitro Cell Dev Biol Anim. 2006;42((7)):176–181. doi: 10.1290/0512089.1. [DOI] [PubMed] [Google Scholar]
  • 8.Hamlet W.P, Liu S.H, Panossian V, Finerman G.A. Primary immunolocalization of androgen target cells in the human anterior cruciate ligament. J Orthop Res. 1997;15((5)):657–663. doi: 10.1002/jor.1100150505. [DOI] [PubMed] [Google Scholar]
  • 9.Liu S.H, al-Shaikh R.A, Panossian V, et al. Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Orthop Res. 1996;14((4)):526–533. doi: 10.1002/jor.1100140405. [DOI] [PubMed] [Google Scholar]
  • 10.Lovering R.M, Romani W.A. Effect of testosterone on the female anterior cruciate ligament. Am J Physiol Regul Integr Comp Physiol. 2005;289((1)):R15–R22. doi: 10.1152/ajpregu.00829.2004. [DOI] [PubMed] [Google Scholar]
  • 11.Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant M.L, Delmarche P. Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exer. 2003;35((3)):439–443. doi: 10.1249/01.MSS.0000053654.14410.78. [DOI] [PubMed] [Google Scholar]
  • 12.Sinha-Hikim I, Taylor W.E, Gonzalez-Cadavid N.F, Zheng W, Bhasin S. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab. 2004;89((10)):5245–5255. doi: 10.1210/jc.2004-0084. [DOI] [PubMed] [Google Scholar]
  • 13.Wiik A, Glenmark B, Ekman M, et al. Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol Scand. 2003;179((4)):381–387. doi: 10.1046/j.0001-6772.2003.01186.x. [DOI] [PubMed] [Google Scholar]
  • 14.Shultz S.J, Kirk S.E, Johnson M.L, Sander T.C, Perrin D.H. Relationship between sex hormones and anterior knee laxity across the menstrual cycle. Med Sci Sports Exerc. 2004;36((7)):1165–1174. doi: 10.1249/01.MSS.0000132270.43579.1A. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Shultz S.J, Gansneder B.G, Sander T.C, Kirk S.E, Perrin D.H. Absolute hormone levels predict the magnitude of change in knee laxity across the menstrual cycle. J Orthop Res. 2006;24((2)):124–131. doi: 10.1002/jor.20021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Romani W, Patrie J, Curl L.A, Flaws J.A. The correlations between estradiol, estrone, estriol, progesterone, and sex hormone-binding globulin and anterior cruciate ligament stiffness in healthy, active females. J Womens Health (Larchmt) 2003;12((3)):287–298. doi: 10.1089/154099903321667627. [DOI] [PubMed] [Google Scholar]
  • 17.Slauterbeck J.R, Hickox M.S, Beynnon B.D, Hardy D.M. Anterior cruciate ligament biology and its relationship to injury forces. Orthop Clin North Am. 2006;37((4)):585–591. doi: 10.1016/j.ocl.2006.09.001. [DOI] [PubMed] [Google Scholar]
  • 18.Yu W.D, Panossian V, Hatch J.D, Liu S.H, Finerman G.A. Combined effects of estrogen and progesterone on the anterior cruciate ligament. Clin Orthop Rel Res. 2001;383:268–281. doi: 10.1097/00003086-200102000-00031. [DOI] [PubMed] [Google Scholar]
  • 19.Comerford E.J, Tarlton J.F, Avery N.C, Bailey A.J, Innes J.F. Distal femoral intercondylar notch dimensions and their relationship to composition and metabolism of the canine anterior cruciate ligament. Osteoarthritis Cartilage. 2006;14((3)):273–278. doi: 10.1016/j.joca.2005.09.001. [DOI] [PubMed] [Google Scholar]
  • 20.Comerford E.J, Tarlton J.F, Innes J.F, Johnson K.A, Amis A.A, Bailey A.J. Metabolism and composition of the canine anterior cruciate ligament relate to differences in knee joint mechanics and predisposition to ligament rupture. J Orthop Res. 2005;23((1)):61–66. doi: 10.1016/j.orthres.2004.05.016. [DOI] [PubMed] [Google Scholar]
  • 21.Lee C.Y, Liu X, Smith C.L, et al. The combined regulation of estrogen and cyclic tension on fibroblast biosynthesis derived from anterior cruciate ligament. Matrix Biol. 2004;23((5)):323–329. doi: 10.1016/j.matbio.2004.07.004. [DOI] [PubMed] [Google Scholar]
  • 22.Komatsuda T, Sugita T, Sano H, et al. Does estrogen alter the mechanical properties of the anterior cruciate ligament? An experimental study in rabbits. Acta Orthop Scand. 2006;77((6)):973–980. doi: 10.1080/17453670610013312. [DOI] [PubMed] [Google Scholar]
  • 23.Liu S.H, al-Shaikh R.A, Panossian V, Finerman G.A, Lane J.M. Estrogen affects the cellular metabolism of the anterior cruciate ligament: a potential explanation for female athletic injuries. Am J Sports Med. 1997;25((5)):704–709. doi: 10.1177/036354659702500521. [DOI] [PubMed] [Google Scholar]
  • 24.Rau M.D, Renouf D, Benfield D, et al. Examination of the failure properties of the anterior cruciate ligament during the estrous cycle. Knee. 2005;12((1)):37–40. doi: 10.1016/j.knee.2003.12.003. [DOI] [PubMed] [Google Scholar]
  • 25.Seneviratne A, Attia E, Williams R.J, Rodeo S.A, Hannafin J.A. The effect of estrogen on ovine anterior cruciate ligament fibroblasts: cell proliferation and collagen synthesis. Am J Sports Med. 2004;32((7)):1613–1618. doi: 10.1177/0363546503262179. [DOI] [PubMed] [Google Scholar]
  • 26.Slauterbeck J, Clevenger C, Lundberg W, Burchfield D.M. Estrogen level alters the failure load of the rabbit anterior cruciate ligament. J Orthop Res. 1999;17((3)):405–408. doi: 10.1002/jor.1100170316. [DOI] [PubMed] [Google Scholar]
  • 27.Strickland S.M, Belknap T.W, Turner S.A, Wright T.M, Hannafin J.A. Lack of hormonal influences on mechanical properties of sheep knee ligaments. Am J Sports Med. 2003;31((2)):210–215. doi: 10.1177/03635465030310020901. [DOI] [PubMed] [Google Scholar]
  • 28.Warden S.J, Saxon L.K, Castillo A.B, Turner C.H. Knee ligament mechanical properties are not influenced by estrogen or its receptors. Am J Physiol Endocrinol Metab. 2006;290((5)):1034–1040. doi: 10.1152/ajpendo.00367.2005. [DOI] [PubMed] [Google Scholar]
  • 29.Wentorf F.A, Sudoh K, Moses C, Arendt E.A, Carlson C.S. The effects of estrogen on material and mechanical properties of the intra- and extra-articular knee structures. Am J Sports Med. 2006;349((12)):1948–1952. doi: 10.1177/0363546506290060. [DOI] [PubMed] [Google Scholar]
  • 30.Woodhouse E, Schmale G.A, Simonian P, Tencer A, Huber P, Seidel K. Reproductive hormone effects on strength of the rat anterior cruciate ligament. Knee Surg Sports Traumatol Arthrosc. 2007;15((4)):453–460. doi: 10.1007/s00167-006-0237-0. [DOI] [PubMed] [Google Scholar]
  • 31.Yu W.D, Liu S.H, Hatch J.D, Panossian V, Finerman G.A. Effect of estrogen on cellular metabolism of the human anterior cruciate ligament. Clin Orthop Rel Res. 1999;366:229–238. doi: 10.1097/00003086-199909000-00030. [DOI] [PubMed] [Google Scholar]
  • 32.Abt J.P, Sell T.C, Laudner K.G, et al. Neuromuscular and biomechanical characteristics do not vary across the menstrual cycle. Knee Surg Sports Traumatol Arthrosc. 2007;15((7)):901–907. doi: 10.1007/s00167-007-0302-3. [DOI] [PubMed] [Google Scholar]
  • 33.Chaudhari A.M, Lindenfeld T.N, Andriacchi T.P, et al. Knee and hip loading patterns at different phases in the menstrual cycle: implications for the gender difference in anterior cruciate ligament injury rates. Am J Sports Med. 2007;35((5)):793–800. doi: 10.1177/0363546506297537. [DOI] [PubMed] [Google Scholar]
  • 34.Dedrick G.S, Sizer P.S, Merkle J.N, et al. Effect of sex hormones on neuromuscular control patterns during landing. J Electromyogr Kinesiol. 2008;18((1)):68–78. doi: 10.1016/j.jelekin.2006.09.004. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Athletic Training are provided here courtesy of National Athletic Trainers Association

RESOURCES